OS Therapies Incorporated

AMEX:OSTX

Biotechnology

Healthcare
$1.15 +5.81%

+$0.10 today

Market cap
$53.83M
Beta
-0.95
P/E (TTM)
-2.0
EPS (TTM)
-$0.91
52W Low $1.15High $2.57

Volume 0.50M

Average 0.71M

OSTX Gross Margin

Gross profit as a percentage of revenue, showing how much of each sales dollar is kept after direct costs.

No reported Gross Margin figures are available to summarize.

Gross Margin history

Percent of revenue · from the income statement

No Gross Margin data reported for this period type.

Gross Margin vs competitors

How OSTX compares with its peers on the latest reported figures

OSTX Competitors Peer median
Gross Margin for OSTX and competitors
Company Period LTM level YoY 3-year change
COEPCoeptis Therapeutics, Inc.LTM Mar 202687.2% +59.0 pp—
HOWLWerewolf Therapeutics, Inc.LTM Jun 202686.4% ——
NRXPNRx Pharmaceuticals, Inc.LTM Mar 202637.1% ——
ADAGAdagene Inc.LTM Jun 2024-14.6% —+0.0 pp
OTLKOutlook Therapeutics, Inc.LTM Mar 2026-360.9% -377.1 pp—
OSTXOS Therapies IncorporatedFY2025— ——
SPRBSpruce Biosciences, Inc.FY2025— ——
EQEquillium, Inc.FY2025— ——
INKTMiNK Therapeutics, Inc.FY2025— ——
Peer median (excluding OSTX) 37.1%-159.0 pp+0.0 pp

Competitors are the stored peer set for OSTX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue1.16M8054.22K2.78K363.09K
Gross Profit(1.16M)(805)(4.22K)(2.78K)(363.09K)
Gross Margin—————
Research & Development2.17M3.29M3.22M2.84M16.36B
Selling, General & Admin1.5M1.15M1.12M3.97M12.34B
Operating Expenses3.68M4.45M4.34M6.81M28.34M
Depreciation & Amortization8058054.22K2.78K363.09K
EBITDA(4.84M)(4.45M)(4.34M)(6.83M)(28.39M)
EBITDA Margin—————
Operating Income(4.84M)(4.45M)(4.34M)(6.81M)(28.71M)
Operating Margin—————
Interest Income0000249
Interest Expense2.58M1.81M3.45M2.05M0
Other Income / Expenses(2.58M)(1.81M)(3.45M)(2.07M)(48.14K)
Income Before Tax(7.42M)(6.25M)(7.79M)(8.88M)(28.75M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(7.42M)(6.25M)(7.79M)(8.88M)(28.75M)
Net Margin—————
EPS (Basic)(0.33)(0.28)(0.39)(0.52)(0.98)
EPS (Diluted)(0.33)(0.28)(0.39)(0.52)(0.98)
Weighted Avg Shares23.1M23.1M20.05M20.87M29.25M
Weighted Avg Shares (Diluted)23.1M23.1M20.05M20.87M29.25M

OS Therapies Incorporated

AMEX:OSTX

Intrinsic Alpha fair value

Locked

Current Price

$1.15

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.